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The Role of Proline-Rich Protein Tyrosine Kinase 2 in
Differentiation-Dependent Signaling in Human
Epidermal Keratinocytes
Eva M. Schindler1, Magdalena Baumgartner1, Erin M. Gribben1, Li Li1 and Tatiana Efimova1
Non-receptor tyrosine kinase proline-rich protein tyrosine kinase 2 (Pyk2) functions as an integrator of multiple
signaling pathways involved in the regulation of fundamental cellular processes. Pyk2 expression, regulation,
and functions in skin have not been examined. Here we investigated the expression and subcellular localization
of Pyk2 in human epidermis and in primary human keratinocytes, and studied the mechanisms of Pyk2
activation by differentiation-inducing stimuli, and the role of Pyk2 as a regulator of keratinocyte differentiation.
We demonstrate that Pyk2 is abundantly expressed in skin keratinocytes. Notably, the endogenous Pyk2 protein
is predominantly localized in keratinocyte nuclei throughout all layers of healthy human epidermis, and in
cultured human keratinocytes. Pyk2 is activated by treatment with keratinocyte-differentiating agents, 12-O-
tetradecanoylphorbol-13-acetate and calcium via a mechanism that requires intracellular calcium release and
functional protein kinase C (PKC) and Src activities. Particularly, differentiation-promoting PKCd and PKCZ elicit
Pyk2 activation. Our data show that Pyk2 increases promoter activity and endogenous protein levels of
involucrin, a marker of keratinocyte terminal differentiation. This regulation is associated with increased
expression of Fra-1 and JunD, activator protein-1 transcription factors known to be required for involucrin
expression. Altogether, these results provide insights into Pyk2 signaling in epidermis and reveal a novel role for
Pyk2 in regulation of keratinocyte differentiation.
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INTRODUCTION
The epidermis is a multilayered self-renewing tissue that
provides essential protection from the environment. A tightly
regulated homeostatic balance of epidermal cell prolifera-
tion, differentiation, and death ensures proper epidermal
structure and function (Eckert et al., 1997; Dotto, 1999; Fuchs
and Raghavan, 2002). The molecular mechanisms that
regulate epidermal homeostasis remain incompletely under-
stood. Therefore, identification and characterization of the
potential regulators of keratinocyte growth and differentiation
as well as elucidation of the regulatory mechanisms are of
fundamental importance.
The proline-rich protein tyrosine kinase 2 (Pyk2) is a non-
receptor tyrosine kinase related to focal adhesion kinase.
Pyk2 is also referred to as related adhesion focal tyrosine
kinase, cell adhesion kinase b, and calcium-regulated protein
tyrosine kinase (Avraham et al., 1995; Lev et al., 1995; Sasaki
et al., 1995; Yu et al., 1996). Pyk2 is activated by a wide
range of stimuli, which induce an increase in intracellular
calcium levels and activation of protein kinase C (PKC)
(Avraham et al., 2000). Pyk2 activation is mediated by
intermolecular autophosphorylation at tyrosine 402 (Y402)
within the N-terminal domain of the kinase (Park et al.,
2004). Phosphorylarion of Y402 correlates with increased
catalytic activity of Pyk2 and facilitates the recruitment and
activation of Src-family tyrosine kinases (Lev et al., 1995; Dikic
et al., 1996; Avraham et al., 2000; Park et al., 2004). Src
activation causes Pyk2 phosphorylation at several other tyrosine
residues, including tyrosines 579 and 580 (Y579, Y580) within
the kinase domain activation loop, and tyrosine 881 (Y881)
within the C-terminal domain of the protein. These phosphor-
ylation events are essential for maximal activation of Pyk2 and
signaling to downstream effectors (Avraham et al., 2000).
Pyk2 transmits extracellular signals that control diverse
cellular functions such as cell proliferation, differentiation,
apoptosis, cytoskeletal remodeling, cell motility and polarity,
pH regulation, and calcium release (Avraham et al., 2000;
Gelman, 2003; Okigaki et al., 2003; Li et al., 2004). As a key
integrator of multiple signaling pathways, Pyk2 receives
activation signals from G protein-coupled receptors, growth
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factor receptors, integrins, as well as environmental stress
agents (ie, UV irradiation) to coordinate the regulation of
numerous downstream signaling intermediates, including Src
family of tyrosine kinases, Rho family GTPases, mitogen-
activated protein kinase (MAPK) cascades (extracellular
signal-regulated kinase 1/2, c-Jun N-terminal kinase 1/2,
and p38), Akt, p70S6K, and NF-kB pathways (Pandey et al.,
1999; Avraham et al., 2000; Shi and Kehrl, 2001; Okigaki
et al., 2003; Banno et al., 2005; Basile et al., 2005). Thus,
Pyk2 is regarded as a convergence point of many important
signaling pathways (Avraham et al., 2000). As these pathways
are involved in transcriptional control, the function of Pyk2 in
the regulation of gene expression has been proposed (Orr and
Murphy-Ullrich, 2004). The functional consequences of Pyk2
activation are diverse and appear to be stimulus- and cell
context-dependent (Avraham et al., 2000; Orr and Murphy-
Ullrich, 2004). Despite an apparent importance of Pyk2
signaling in many cell types, the role of Pyk2 in skin has not
been defined.
In this study, we investigated the expression and sub-
cellular localization of Pyk2 in human epidermis and in
primary human keratinocytes, examined the regulation of
Pyk2 by keratinocyte differentiation-inducing stimuli, and
studied the role of Pyk2 in control of keratinocyte differentia-
tion. Our results suggest that Pyk2 plays a role in regulating
epidermal cell function.
RESULTS
Pyk2 is expressed in normal human epidermal keratinocytes
We first examined endogenous messenger RNA (mRNA) and
protein expression of Pyk2 in normal human epidermal
keratinocytes. As shown in Figure 1a, Pyk2 mRNA expression
was detected in keratinocytes derived from two donors, by
RNA extraction and RT-PCR analysis using Pyk2-specific
primers. We then assessed Pyk2 protein expression in
keratinocytes by immunoblot analysis using Pyk2-specific
antibody. As shown in Figure 1b, keratinocytes exhibit high
level of endogenous Pyk2 protein expression comparable to
that in neuroendocrine PC12 cells, a model system in which
endogenous Pyk2 expression is particularly robust (Lev et al.,
1995). Taken together, these data indicate that Pyk2 is
abundantly expressed in human epidermal keratinocytes.
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Figure 1. Pyk2 is expressed in primary human keratinocytes and localized in the nucleus. (a) Third passage normal human foreskin keratinocytes derived from
donors 1 and 2 were cultured in keratinocyte serum-free medium until approximately 80% confluent. Total RNA was then extracted from the cells, and Pyk2
mRNA levels were assessed by RT-PCR. b-Actin levels were monitored as a control to assure equal loading. (b) Total cell extracts were prepared from
keratinocytes cultured as described in (a), and assayed for Pyk2 protein expression by immunoblot using anti-Pyk2 antibody. PC12 cell extract was used as a
positive control. Equal amounts of protein (40mg per lane) were used in this assay. b-Actin level was assayed to verify equal protein loading. (c) Keratinocytes
growing on coverslips were fixed, permeabilized, immunostained with a mouse monoclonal anti-Pyk2 antibody followed by Cy3-conjugated goat anti-mouse
IgG, and examined by laser scanning confocal microscopy. Nuclei were stained with Hoechst dye and visualized under a fluorescence microscope. Bar¼ 25mM
(d) Keratinocytes were cultured as described in (a). Nuclear (N) and cytosolic (C) fractions were prepared, and assayed for Pyk2 expression by immunoblot using
a mouse monoclonal (C-terminal) anti-Pyk2 antibody. (Parallel blots were probed with a rabbit polyclonal (N-terminal) anti-Pyk2 antibody with analogous
results, not shown) Successful separation of the nuclear and cytosolic fractions was confirmed by detection of poly(ADP-ribose) polymerase, a nuclear protein,
exclusively in the nuclear fraction. PKCd protein is equally distributed between the nuclear and the cytosolic fractions, ensuring equivalent gel loading.
(e) Subnuclear distribution of Pyk2. Images shown in (c and e) are representative of at least five independent experiments using cells isolated from foreskins
derived from different donors; data shown in (d) are representative of four independent experiments.
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Pyk2 is localized predominantly in the cell nucleus in cultured
human keratinocytes and in epidermis
We next studied a subcellular localization of endogenous
Pyk2 in normal human epidermal keratinocytes and in
healthy human epidermis using immunofluorescence and
confocal microscopy methods. As shown in Figure 1c, in
keratinocytes maintained under basal unstimulated condi-
tions, very prominent Pyk2 staining is observed in the
nucleus. Some diffuse cytoplasmic staining is also noticeable.
The nuclear localization of Pyk2 is corroborated by the use of
two different antibodies specific either to the N-teminal
region (amino acids 1–102, H-102, Santa Cruz Biotechnology
(Santa Cruz, CA); data not shown) or the C-terminal region of
Pyk2 (amino acids 833–997, clone 11, BD Biosciences (San
Jose, CA)) (Figure 1c and e). Omission of the primary
antibody resulted in only minor background staining detect-
able in the cytoplasm and virtually no signal detectable in the
nucleus, verifying the specificity of immunostaining (data not
shown). The nuclear localization of Pyk2 protein was
confirmed biochemically by isolating nuclear fraction of
keratinocytes and immunoblotting with Pyk2-specific anti-
body. As shown in Figure 1d, Pyk2 immunoreactivity is
predominantly detected in the nuclear fraction. Figure 1e
shows that Pyk2 is diffusely distributed throughout the
nucleoplasm in small clusters or foci.
We next investigated the expression and distribution of
Pyk2 protein in healthy human epidermis. Staining of human
neonatal foreskin epidermis shows Pyk2 expression in the
nuclei throughout all epidermal layers (Figure 2a). A similar
pattern is observed in normal adult epidermis (Figure 2b).
Some punctuate plasma membrane staining is also detectable
(Figure 2b, right panel, the thin arrows; enlarged image is
shown on the left panel of the Figure 2b, the thick arrows
point to plasma membrane staining). Negative control
without primary antibody shows minor background staining
(Figure 2c) confirming the specificity of Pyk2 staining.
Pyk2 is activated by regulators of keratinocyte differentiation
Cultured human keratinocytes can be induced to differentiate
by administration of TPA or by elevation of the calcium
concentration in the culture medium (Wirth et al., 1987;
Yuspa et al., 1988; Younus and Gilchrest, 1992; Eckert et al.,
1997; Bikle et al., 2001). We examined the effects of these
differentiating agents on the activation status, the expression
levels, and the subcellular distribution of Pyk2 in keratino-
cytes. Pyk2 tyrosine phosphorylation has been shown to
correlate with Pyk2 kinase activation (Avraham et al., 2000).
We first assessed the effect of TPA on phosphorylation of
Pyk2 on Y402, a major site of Pyk2 autophosphorylation upon
activation, using phospho-Y402-specific antibody. As shown
in Figure 3a, TPA administered at 100 ng/ml markedly
increased Pyk2 phosphorylation in a time-dependent man-
ner. The signal was maximal at 1 hour and persisted for up to
6 hours post-stimulation (Figure 3a). Phosphorylation of other
tyrosine residues essential for maximal Pyk2 activation,
including Y579 and Y580 in the kinase domain activation
loop, and Y881 in the C-terminal domain of Pyk2, was
induced by TPA treatment with the similar time course (not
shown). As shown in Figure 3b, TPA-induced Pyk2 phos-
phorylation was inhibited by BAPTA-AM, a membrane-
permeable intracellular calcium chelator, by PKC inhibitor
bis-indolylmaleimide (BIS-IM), and by Src family kinase
Pyk2
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Figure 2. Immunolocalization of Pyk2 in human epidermis. Paraffin-embedded sections of (a) healthy human foreskin or (b) healthy adult human skin were
deparaffinized and immunostained with a mouse monoclonal anti-Pyk2 primary antibody followed by Cy3-conjugated goat anti-mouse secondary antibody, and
examined by laser scanning confocal microscopy. Nuclei were counterstained with Hoechst dye and visualized under a fluorescence microscope. In (b), the thin
arrows in the right panel and the thick arrows in the enlarged image in the right panel, point to the punctuate plasma membrane staining. *Marks nuclei of
granular layer cells. (c) Control section with secondary antibody only. Dashed lines, dermal–epidermal junction. Bars¼ 25 mM. Images are representative of at
least five independent experiments.
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inhibitor PP2. In contrast, Pyk2 activation by TPA was
unaffected by LY294002, a phosphatidylinositol 30-kinase
inhibitor (Figure 3b). These results indicate that the increase
in intracellular calcium levels as well as functional PKC and
Src-type kinase activities are required for TPA-induced
activation of Pyk2 in keratinocytes, whereas phosphatidyli-
nositol 30-kinase activity is dispensable for this regulation.
Novel (calcium-independent) protein kinase C (nPKC)
isoforms d and Z play a role in transmitting differentiation-
promoting signal in human keratinocytes (Ohba et al., 1998;
Cabodi et al., 2000; Efimova and Eckert, 2000; Kashiwagi
et al., 2000; Efimova et al., 2002). As TPA activates PKCd and
PKCZ in keratinocytes, we examined the effect of adenovirus-
mediated expression of these PKC isoforms on Pyk2 tyrosine
phosphorylation. As shown in Figure 3c, overexpression of
PKCd and PKCZ enhanced Pyk2-Y402 phosphorylation as
compared to keratinocytes infected with the empty control
adenovirus. These observations suggest that PKCd and PKCZ
are candidate upstream regulators of Pyk2 in keratinocytes.
The role for PKCd in this regulation is further supported
by our finding that pretreatment of the cells with rottlerin,
a PKCd-selective inhibitor (Gschwendt et al., 1994), blocks
TPA-induced activation of Pyk2 in keratinocytes (Figure 3d).
These data suggest that PKC isoforms d and Z mediate
TPA-induced activation of Pyk2 in human epidermal
keratinocytes.
Calcium is a key regulator of keratinocyte differentiation.
Notably, Pyk2 has been suggested to function both as a
calcium sensor and as an element essential for the control of
calcium release in response to extracellular cues (Lev et al.,
1995; Avraham et al., 2000; Okigaki et al., 2003). It is
therefore of interest to determine whether Pyk2 plays a role in
mediating calcium-induced differentiation in human kerati-
nocytes. As shown in Figure 3e, Pyk2 activity is increased in
keratinocytes treated with 1.2 mM calcium. Additional studies
are needed to determine which specific molecules transduce
calcium signal to activate Pyk2 in keratinocytes. Candidate
regulators include PKC and Src families of kinases (Deucher
et al., 2002; Xie et al., 2005). Taken together, our findings
that the activation of Pyk2 is stimulated by keratinocyte
differentiation-inducing agents, suggest that Pyk2 may play a
role in mediating the effects of these agents in human
keratinocytes.
Treatment with differentiating agents does not alter subcellular
localization of endogenous Pyk2 protein
As shown in Figure 3a and e, treatment of keratinocytes with
TPA or calcium had little effect on the total level of the
endogenous Pyk2 protein in these cells. We next examined
whether the subcellular localization of the endogenous Pyk2
protein was affected by treatment of keratinocytes with these
agents. As shown in Figure 4a, Pyk2 remained predominantly
nuclear after treatment with TPA or calcium for various time
periods. Nuclear extract isolation experiments confirm the
confocal microscopy data and show that the nuclear Pyk2
levels are not altered by treatment with the differentiating
agents for up to 24 hours (TPA treatment) or 48 hours (calcium
treatment) (Figure 4b).
Immunolocalization of Y402-phosphorylated Pyk2 in
keratinocytes
To determine the intracellular distribution of activated
phosphorylated Pyk2, and to investigate the impact of
calcium and TPA treatment on this distribution, we immu-
nostained keratinocytes, treated in the absence (Control) or in
the presence of 1.2 mM calcium (Calcium), or 100 ng/ml TPA,
with anti-pY402-Pyk2 antibody, and examined the cells using
confocal laser scanning microscopy. As shown in Figure 5
(left panel), in unstimulated cells, pY402-Pyk2 immunoreac-
tivity is relatively low and is only just detectable at the cell
periphery and at the sites of focal contacts. In cells treated
with calcium or TPA, the amount of phosphorylated activated
Pyk2 is markedly increased. This is in agreement with the
data provided by immunoblot analysis (Figure 3a and e). Of
note, activated Pyk2 is localized prominently in the nucleus.
This observation, along with data presented in Figures 3 and
4, suggests that Pyk2, activated by differentiation-promoting
stimuli, may function in the nucleus to regulate epidermal
gene transcription and/or other critical nuclear processes.
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Figure 3. Pyk2 is activated by regulators of keratinocyte differentiation.
Keratinocytes were cultured as described in Figure 1a, and treated with (a, b,
d) 100 ng/ml TPA or (e) 1.2 mM calcium, as indicated, or (c) infected with
empty control adenovirus (EV), or adenoviral vectors encoding PKCZ or PKCd
isoforms at a multiplicity of infection¼15 for 24 hours. (The expression of
adenovirus-delivered proteins was confirmed by immunoblot, not shown). In
(b and d) keratinocytes were pretreated for 30 minutes with or without each of
the indicated inhibitors at the following concentrations: (b) 50 mM BAPTA-AM,
10mM BIS-IM, 5 mM PP2, or 2mM LY 294002; or (d) 10 mM Rottlerin. The cells
were then treated in the absence or presence of 100 ng/ml TPA for (b) 1 hour
or (d) 30 minutes (Inhibitor treatment alone did not influence Pyk2
phosphorylation status, not shown). Total cell extracts were prepared, and
Pyk2 activation was assessed by measuring its phosphorylation on tyrosine
402 (Y402), a major autophosphorylation site, using phosphotyrosine
402-specific antibody (pY402-Pyk2). Total Pyk2 level was monitored using
anti-Pyk2 antibody. b-Actin level was assayed to assure equal protein loading.
The data presented in each panel are representative of at least three
independent experiments.
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Figure 4. Treatment with differentiating agents does not affect subcellular localization of endogenous Pyk2 protein. (a) Keratinocytes growing on coverslips
were cultured in culture medium with 0.03 mM calcium (Control), or treated with 1.2 mM calcium or 100 ng/ml TPA for the indicated periods of time, fixed,
permeabilized, and immunostained with a monoclonal mouse anti-Pyk2 antibody followed by Cy3-conjugated goat anti-mouse IgG, and examined by laser
scanning confocal microscopy. Bars¼25 mM. (b) Cultured human keratinocytes were treated without (untreated), or with 100 ng/ml TPA, or 1.2 mM calcium. The
cells were harvested and nuclear extracts were prepared at the time points indicated. The protein levels of Pyk2 were assessed by immunoblot using anti-Pyk2
antibody. Equal protein loading was verified by membrane stripping and reprobing with antibody specific to nuclear marker proteins poly(ADP-ribose)
polymerase and Lamin A/C (not shown). Data presented in each panel are representative of three independent experiments.
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In addition, there is an enrichment of the pY402-Pyk2
immunoreactivity at the sites of focal contacts in cells treated
with calcium or TPA in comparison with control cells.
Notably, the anti-Pyk2 antibody used in the experiment
depicted in Figure 4a, failed to detect Pyk2 signal at the cell
periphery and at the sites of focal contacts (compare Figures
4a and 5). To account for these observations, it is instructive
to consider the antibody sensitivity issues raised by Naka-
mura et al. (2001). As reported by Nakamura and co-workers,
the mouse monoclonal anti-Pyk2 antibody directed against
C-terminal region of Pyk2 (amino acids 833–997, clone 11,
BD Biosciences, which we utilized in the experiment shown
in Figure 4a), has been found to be very inefficient in
detecting Pyk2 molecules localized at focal adhesions
(Nakamura et al., 2001; Gelman, 2003). In parallel experi-
ments, when we utilized an alternative anti-Pyk2 antibody
specific to the N-terminal region of the molecule (amino
acids 1–102, Santa Cruz Biotechnology), we were able to
detect a small subset of Pyk2 localized at the cell periphery
in unstimulated cells (not shown). Significantly, both the
C-terminal and the N-terminal anti-Pyk2 antibodies detect
the majority of the Pyk2 immunoreactivity in the nucleus.
Regulation of hINV promoter activity by Pyk2
Our data show that Pyk2 is activated by keratinocyte-
differentiating agents (Figures 3 and 5). To begin evaluating
the effect of this regulation on differentiation, we examined
the regulation of human involucrin (hINV) promoter by Pyk2.
Involucrin is a marker of keratinocyte terminal differentiation
(Rice and Green, 1979; Eckert et al., 1997, 2004). This
soluble cytoplasmic protein precursor of the keratinocyte
cornified envelope is specifically expressed in the suprabasal
(late spinous and granular) epidermal layers (Rice and
Green, 1979; Eckert et al., 1997, 2004). In cultured human
epidermal keratinocytes, hINV mRNA, and protein levels, as
well as the promoter activity, are increased by treatment with
keratinocyte differentiation-promoting agents, including TPA
and calcium (Younus and Gilchrest, 1992; Yaar et al., 1993;
Welter et al., 1995; Efimova et al., 1998). Moreover, we have
previously shown that TPA-induced increase in hINV mRNA
and protein expression and promoter activity are inhibited
by pretreatment with genistein, a tyrosine kinase inhibitor
(Efimova et al., 1998). We therefore evaluated the effect of
Pyk2 on hINV promoter activity using a co-transfection
approach. We co-transfected with pINV-2473, a luciferase-
linked hINV promoter reporter plasmid, and either empty
control expression vector, or Pyk2-encoding expression
plasmid. The cultures were additionally treated with or
without 50 ng/ml TPA (Figure 6a). We then monitored the
effects on the promoter activity. As shown in Figure 6a, Pyk2
expression causes an approximately 12-fold increase in hINV
promoter activity, which is similar to the extent of the TPA-
stimulated induction of the promoter activity. When Pyk2-
expressing cells are treated with TPA, the resulting hINV
promoter activation is greatly enhanced (over 40-fold
induction, Figure 6a). The inset in Figure 6a confirms that
vector-delivered Pyk2 is expressed at an appropriate level. As
a control, we also examined the impact of Pyk2 on hINV
minimal promoter construct, pINV-41, which contains only
the hINV TATA box (Welter et al., 1995; Efimova et al.,
1998). As expected, pINV-41 was not active and did not
respond to either Pyk2 or TPA (data not shown).
Differential effect of PKC inhibitor BIS-IM on TPA- and Pyk2-
stimulated hINV promoter activity
We have previously reported that BIS-IM, a specific PKC
inhibitor, blocks TPA-induced increase in hINV expression,
suggesting a role for PKC in mediating TPA-dependent hINV
expression (Efimova et al., 1998; Efimova and Eckert, 2000).
To evaluate the effects of PKC inhibition on Pyk2-mediated
activation of hINV promoter, we co-transfected keratinocytes
with the full-length promoter construct, pINV-2473, and
Pyk2-encoding expression plasmid, and treated cells with or
without 5 mM BIS-IM. In parallel, we treated keratinocytes co-
transfected with pINV-2473 and empty control expression
vector, with or without 50 ng/ml TPA for 24 hours, in the
presence or absence of 5 mM BIS-IM. In agreement with our
previous report (Efimova et al., 1998), BIS-IM inhibited TPA-
stimulated hINV promoter activity (Figure 6b). In contrast,
Pyk2-dependent hINV promoter activity was not suppressed
by BIS-IM (Figure 6b). These findings, together with the data
presented in Figure 3c, are consistent with the concept that
pY402-Pyk2 pY402-Pyk2 pY402-Pyk2Control Calcium TPA
Figure 5. Immunolocalization of pY402-Pyk2 in keratinocytes. Cells growing on coverslips were cultured in culture medium with 0.03 mM calcium (Control), or
treated with medium containing 1.2 mM calcium (Calcium), or 100 ng/ml TPA (TPA) for 2 hours, fixed, permeabilized, and immunostained with rabbit polyclonal
anti-pY402-Pyk2 antibody followed by Alexa Fluor-conjugated goat anti-rabbit IgG, and examined by laser scanning confocal microscopy. No staining was
observed when normal rabbit IgG was used in place of primary antibody, confirming the specificity of signal (not shown). Bar¼ 25mM. Data shown are
representative of three independent experiments.
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Pyk2 acts downstream of PKC (ie, nPKC isoforms d and Z) in a
pathway leading to hINV promoter activation.
Pyk2 regulates expression of the endogenous hINV gene
The above data show that Pyk2 activates hINV promoter
expression. To determine if this regulation is physiologically
relevant, we examined the effect of Pyk2 on endogenous
hINV expression. Keratinocytes were infected with the
control green fluorescent protein (GFP)-encoding adenovirus
or adenovirus encoding GFP-tagged Pyk2 (Heidkamp et al.,
2005). At 24 hours post-infection, the cells were treated for an
additional 24 hours with or without 50 ng/ml TPA. The cells
were then harvested and total cell extracts were prepared for
immunoblot analysis. We first confirmed the expression of
adenoviral vector-delivered GFP-tagged Pyk2 (Ad-GFP-
Pyk2). As shown in Figure 7a (upper panel), Ad-GFP-Pyk2
is expressed as an approximately 150-kDa fusion protein that
is readily distinguished from the endogenous Pyk2 protein
(116 kDa) (Litvak et al., 2000; Heidkamp et al., 2005). Ad-
GFP-Pyk2 was also detected using anti-GFP antibody (Figure
7a). Immunoblotting using anti-pY402-Pyk2 antibody revealed
that overexpressed wild-type Pyk2 undergoes autophosphor-
ylation (Figure 7a). This finding is consistent with previous
reports (Litvak et al., 2000; Heidkamp et al., 2005), and
indicates that adenovirus-mediated expression of wild-type
Pyk2 results in a constitutive activation of this protein and
stimulates Pyk2-dependent signaling (Heidkamp et al., 2005).
Moreover, treatment of Pyk2-expressing keratinocytes with
TPA increased autophosphotylation levels of Ad-GFP-Pyk2
(not shown), demonstrating that regulation of adenovirully
delivered Pyk2 by TPA is analogous to that observed
for endogenous Pyk2 (Figure 3a). Thus, Ad-GFP-Pyk2 appears
to provide a useful tool for studying the functional
consequences of Pyk2-mediated signaling on keratinocyte
function.
We next examined the effect of Pyk2 expression on the
endogenous hINV protein level. As shown in Figure 7b, hINV
protein level is markedly increased in keratinocytes expres-
sing Pyk2. The increase in involucrin protein level produced
by Pyk2 is similar to that elicited by TPA treatment. Involuctin
protein expression is further enhanced in Pyk2-expressing
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Figure 6. Pyk2 increases hINV promoter activity. (a) Cultured human
keratinocytes were transfected with the full-length hINV promoter construct
that includes 2,473 bp of the hINV promoter region linked to the luciferase
reporter gene in pGL2-Basic plasmid, and empty control expression vector or
plasmid encoding FLAG epitope-tagged wild-type Pyk2 (Pyk2wt). After
48 hours, the cells were treated with culture medium in the absence or
presence of 50 ng/ml TPA for an additional 24 hours. The cells were then
harvested and lysates were assayed for luciferase activity. Luciferase activity
was normalized per (mg) of protein. The expression of vector-produced Pyk2
was confirmed by immunoblot using anti-FLAG antibody (inset). Data shown
are mean7SE of five independent experiments, each performed in triplicate.
RLU – relative luciferase units. (b) Differential effects of PKC inhibitor BIS-IM
on TPA- and Pyk2-dependent hINV promoter activity. Cultured human
keratinocytes were transfected with pINV-2473 reporter plasmid and empty
control expression vector (vector) or plasmid encoding wild-type Pyk2
(Pyk2wt). 24 hours post-transfection, the cells were treated in the presence or
the absence of 5 mM BIS-IM for additional 24 hours. Parallel vector-transfected
dishes were treated for 24 hours with or without 50 ng/ml TPA (vectorþ TPA).
BIS-IM was added 30 minutes before addition of TPA. Cell extracts were
assayed for luciferase activity. Data shown are mean7SE of three
independent experiments, each performed in triplicate.
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Figure 7. Pyk2 increases endogenous hINV levels. (a) Keratinocytes were
infected with control GFP-encoding adenovirus (Ad-GFP), or adenovirus
encoding GFP-tagged Pyk2 (Ad-GFP-Pyk2) at a multiplicity of infection of 30.
After 48 hours, the cells were harvested, total cell extracts were prepared, and
expression of adenovirus-delivered Pyk2 was confirmed by immunoblot using
anti-Pyk2 antibody and anti-GFP antibody. b-Actin levels were monitored to
assure equal loading. The phosphorylation status of Pyk2 was monitored using
phospho-tyrosine 402-specific antibody (pY402-Pyk2). (b) Keratinocytes were
infected with the indicated adenovirus as described in (a). At 24 hours post-
infection, the cells treated in the absence or presence of 50 ng/ml TPA for an
additional 24 hours, total cell extracts were then prepared, and involucrin
protein expression was assessed by immunoblot. b-Actin was used as a
loading control. Data shown are representative of five independent
experiments performed using cells derived from different donors. (c) Pyk2
induces tyrosine phosphorylation of Src in keratinocytes. Cells were infected
with the indicated adenovirus as detailed in (a). Total cell extracts were
prepared 48 hours post-infection, and the levels of phosphorylation of Src on
tyrosine 416, which is indicative of Src enzymatic activity, was assessed by
immunoblot using phosphotyrosine 416-specific antibody (pY416-Src). Total
Src levels were measured using anti-Src antibody. Data shown are
representative of at least three independent experiments.
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cells treated with TPA. Collectively, the data shown in Figures
6 and 7 suggest that Pyk2 is involved in regulation of hINV
gene expression during keratinocyte differentiation process.
Pyk2 increases activation of the endogenous Src
Keratinocyte differentiation-promoting agents have been
shown to stimulate the activity of Src family of tyrosine
kinases, including Src and Fyn family members (Zhao et al.,
1992; Calautti et al., 1995; Cabodi et al., 2000; Xie et al.,
2005). Moreover, Src activity has been found to be essential
for key differentiation-associated responses, including induc-
tion of hINV expression (Xie et al., 2005). Our data (Figures 6
and 7) indicate that Pyk2 regulates hINV expression in
keratinocytes. In addition, Pyk2 has been demonstrated to
promote Src activation in several cell systems (Dikic et al.,
1996; Avraham et al., 2000). We therefore explored the
impact of Pyk2 expression on the endogenous Src activity in
cultured human keratinocytes. As shown in Figure 7c, Ad-
GFP-Pyk2 increased levels of phosphorylated activated form
of Src. In contract, total Src protein levels were not affected
by Ad-GFP-Pyk2 treatment (Figure 7c).
Pyk2 increases levels of AP-1 transcription factors Fra-1
and JunD
Activator protein-1 (AP-1) is the major transcription factor
involved in control of keratinocyte maturation (Eckert and
Welter, 1996; Angel et al., 2001; Hess et al., 2004).
Differentiation-promoting agents have been shown to reg-
ulate expression of differentiation marker genes via activation
of PKC-dependent signaling pathway that targets AP-1
proteins (Eckert and Welter, 1996; Angel et al., 2001). AP-
1-dependent regulation of hINV gene has been reported
previously (Welter et al., 1995; Efimova et al., 1998; Ng
et al., 2000). Earlier studies have identified Fra-1 and JunD
among the key AP-1 transcriptional regulators that are
required for hINV expression (Welter et al., 1995; Ng et al.,
2000; Hanley et al., 2001; Balasubramanian et al., 2002;
Eckert et al., 2004). To determine whether Pyk2-stimulated
increase in hINV expression is associated with changes in the
Fra-1 and JunD levels, we isolated nuclear extracts from
keratinocytes expressing either control GFP adenovirus, or
Pyk2 adenovirus in the presence or absence of TPA, and
monitored Fra-1 and JunD expression levels by immunoblot.
As shown in Figure 8, cells expressing Pyk2 exhibit higher
levels of nuclear Fra-1 and JunD expression. As a positive
control, we show that TPA treatment causes a comparable
increase in the amounts of these proteins. Notably, Pyk2-
expressing cells treated with TPA demonstrate markedly
augmented levels of Fra-1 and JunD. This robust induction is
very similar to the effect of the simultaneous treatment with
Pyk2 and TPA on hINV protein levels (Figure 7b). Altogether,
these results suggest that Pyk2 mediates differentiation-
stimulated hINV gene expression through a mechanism that
involves AP-1 transcription factors Fra-1 and JunD.
DISCUSSION
Maintenance of proper epidermal function requires a precise
balance of skin cell growth, differentiation, and death (Eckert
et al., 1997; Dotto, 1999; Fuchs and Raghavan, 2002;
Okuyama et al., 2004). Disturbances in control of this
balance result in compromised barrier function and con-
tribute to a variety of skin diseases as well as aberrant wound
healing. Although our understanding of the signal-transduc-
tion networks involved in control of epidermal keratinocyte
growth and differentiation has improved considerably in
recent years, much remains to be learned, particularly
relating to the mechanisms by which multiple signaling
pathways are integrated to ensure a specific biological
outcome (LeFort and Dotto, 2004). In this regard, the non-
receptor protein tyrosine kinase Pyk2 has been shown to act
as a convergence point of many signaling pathways
implicated in control of vital cellular processes in a variety
of organ systems (Avraham et al., 2000; Orr and Murphy-
Ullrich, 2004). Of note, a large number of signaling proteins
reportedly involved in a molecular crosstalk with Pyk2 has
also been implicated in the control of keratinocyte growth
and differentiation, including PKC isoforms, Src family
kinases, Rho family GTPases, phospholipase D, MAPK
extracellular signal-regulated kinase 1/2, c-Jun N-terminal
kinase 1/2, and p38 MAPK, Akt, and NF-kB (Pandey et al.,
1999; Avraham et al., 2000; Shi and Kehrl, 2001; Okigaki
et al., 2003; Eckert et al., 2004; LeFort and Dotto, 2004;
Banno et al., 2005; Basile et al., 2005). Intriguingly, recent
data have suggested a role for Pyk2 as a potential regulator of
the intracellular calcium release in response to extracellular
cues (Okigaki et al., 2003). Yet, despite the important
signaling roles attributed to Pyk2 in other cell types, the
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Figure 8. Pyk2 increases levels of AP1 transcription factors Fra-1 and JunD.
Keratinocytes were infected with control GFP-encoding adenovirus (Ad-GFP),
or adenovirus encoding GFP-tagged Pyk2 (Ad-GFP-Pyk2) at a multiplicity of
infection of 30. After 24 hours the cells were treated in the absence or
presence of 50 ng/ml TPA for an additional 24 hours. Nuclear extracts were
then prepared and AP1 factor expression was monitored by immunoblot using
an appropriate AP-1 factor-specific antibody. p38d Level was assayed to
assure equal protein loading, as a substantial quantity of the endogenous p38d
protein have been shown to reside in the nucleus in keratinocytes (Efimova
et al., 2004).
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expression, regulation, and function of Pyk2 in epidermal
keratinocytes has not been well studied. Our current studies
implicate the non-receptor protein tyrosine kinase Pyk2 as a
potential novel regulator of keratinocyte function.
In the present report, we demonstrate that Pyk2 is
expressed at high levels in healthy human epidermal tissues
(Figure 2) and in cultured normal human epidermal
keratinocytes (Figure 1). Remarkably, both the immunoloca-
lization studies and biochemical fractionation experiments
show that Pyk2 is localized predominantly in the nuclear
compartment in these cells. Immunofluorescence and laser
scanning confocal microscopy studies show that Pyk2 is
diffusely distributed throughout the nucleoplasm in small
clusters or foci (Figure 1c and e). The functional nature of
these foci is presently being investigated in our laboratory.
The unique nuclear localization of the endogenous Pyk2
protein in epidermis suggests that Pyk2 plays a role in
regulation of epidermal gene expression and/or other nuclear
processes.
Our studies show that keratinocyte differentiation-promot-
ing stimuli, including TPA, calcium, and nPKC isoforms d and
Z increase the levels of tyrosine-phosphorylated activated
Pyk2 in cultured cells (Figure 3). The TPA-stimulated increase
in tyrosine phosphorylation of Pyk2 is greatly reduced by
BAPTA-AM, an intracellular calcium chelator, by the PKC
inhibitor BIS-IM, and Src family kinase inhibitor PP2 (Figure
3b), as well as by PKCd-selective inhibitor rottlerin (Figure
3d). Taken together, these findings indicate that differentia-
tion-dependent Pyk2 signaling in keratinocytes is mediated
by a pathway that requires elevated intracellular calcium
levels and activation of PKC (ie, nPKC d and Z) and Src family
kinase(s) upstream of Pyk2. Previous studies show that nPKC
isoforms d and Z play a key role in transmitting differentiation
signal in human keratinocytes (Ohba et al., 1998; Cabodi
et al., 2000; Efimova and Eckert, 2000; Kashiwagi et al.,
2000; Efimova et al., 2002). Pyk2 activation by diverse
stimuli in different cell types has been documented to require
a PKCd activity (Soltoff et al., 1998; Wrenn, 2001; Frank
et al., 2002; Shah and Catt, 2002; Farshori et al., 2003). In
some systems, PKCa and PKCe isoforms have also been
reported to participate in Pyk2 activation (Cheng et al., 2002;
Bayer et al., 2003; Rucci et al., 2005). The involvement of
these PKC family members in differentiation-dependent
activation of Pyk2 in keratinocytes remains to be analyzed.
Remarkably, Pyk2 and PKC family members have been
demonstrated to undergo direct physical and functional
interactions, and assemble into a multiprotein signaling
complex that also includes Src family kinases (Andreev
et al., 2001; Wrenn, 2001; Cheng et al., 2002; Shah and Catt,
2002; Farshori et al., 2003; Rucci et al., 2005). Specific
members of the Src family of tyrosine kinases, including Src
and Fyn, have been implicated in promoting keratinocyte
differentiation (Zhao et al., 1992; Calautti et al., 1995;
Cabodi et al., 2000; Xie et al., 2005). Src and Fyn protein
levels and intrinsic enzymatic activities have been shown to
be increased in human or mouse keratinocytes induced to
differentiate by calcium treatment (Zhao et al., 1992; Calautti
et al., 1995; Xie et al., 2005). Differentiation-promoting PKCZ
has been reported to function as a direct upstream activator of
Fyn in a signaling pathway leading to growth arrest and
differentiation in mouse keratinocytes (Cabodi et al., 2000).
Fyn, in turn, has been shown to activate Pyk2 is some cell
systems (Qian et al., 1997). Increased Fyn activity in mouse
keratinocytes promotes expression of differentiation markers
transglutaminase and filaggrin (Cabodi et al., 2000). Interest-
ingly, both Src and Fyn, but not Src or Fyn alone, appear to be
required for calcium-stimulated human keratinocyte differ-
entiation and for calcium-induced expression of involucrin
and transglutaminase (Xie et al., 2005). These findings
suggest that both Src and Fyn may function as Pyk2 signaling
partners in keratinocyte differentiation regulatory pathway.
Importantly, while Src activity is required for Pyk2 activation,
Pyk2, in turn, is essential for activation of Src; this
interdependent loop-like activation mechanism involving
Pyk2 and Src has been reported previously (Dikic et al.,
1996). In agreement with this notion, our data indicate that
increased levels of Pyk2 in keratinocytes are associated with
activation of endogenous Src family kinases, as evidenced by
enhanced phosphorylation of Src on tyrosine 416 in cells
overexpressing Pyk2 when compared with vector-expressing
cells (Figure 7c). (Phosphorylation on tyrosine 416 reflects
increased enzymatic activity of Src kinases). As activation of
Src family kinases has been reported to be required for
human keratinocyte differentiation (Xie et al., 2005), our
results are consistent with the concept that activation of Pyk2
signaling, in part through activation of Src pathway, promotes
induction of human keratinocyte differentiation program as
evidenced by induction of expression of involucrin (Figures 6
and 7b), a terminal differentiation marker of the intermediate
epidermal layers. Further investigations will be required to
determine whether Pyk2 signaling is involved in regulation of
other aspects of epidermal keratinocyte differentiation (ie, the
effect of Pyk2 on expression of other early (keratin 1/10,
transglutaminase) and late (loricrin and filaggrin) differentia-
tion markers).
Notably, activation of Pyk2 by treatment with differentia-
tion agents does not appear to alter nuclear distribution of the
kinase (Figure 4). Moreover, the majority of activated
phosphorylated Pyk2 is found in the nuclei of differentiating
keratinocytes, whereas a subset of phosphorylated Pyk2
accumulates at the sites of cell–cell contacts and at focal
adhesions (Figure 5) suggesting a potential regulatory role for
Pyk2 at these locations (Avraham et al., 2000; Du et al.,
2001; van Buul et al., 2005). The functional significance of
the Pyk2 nuclear residence and the nature of the potential
Pyk2 nuclear targets in skin cells are presently unknown and
require further studies. We speculate that in addition to gene
expression regulation by means of stimulation of cytoplasmic
signaling pathways (Avraham et al., 2000; Orr and Murphy-
Ullrich, 2004), Pyk2 localized to the nuclear compartment
may be involved in transcriptional modulation via direct
action on specific nuclear substrates.
As mentioned above, our data show that Pyk2 signaling
activates expression of terminal differentiation marker gene
involucrin in cultured human epidermal keratinocytes. The
induction of hINV expression by Pyk2 is correlated with
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increased expression of Fra-1 and JunD (Figure 8), the AP-1
transcription factor proteins identified by previous studies as
key regulators of hINV expression (Welter et al., 1995; Ng
et al., 2000; Hanley et al., 2001; Balasubramanian et al.,
2002; Eckert et al., 2004). These findings suggest that Pyk2
may function as a bona fide regulator of keratinocyte
maturation by mediating differentiation-induced gene ex-
pression downstream of PKC activation, via AP-1-dependent
mechanism. Our previous studies have developed hINV gene
as an advanced model for studying how differentiation-
dependent gene expression is regulated in normal human
keratinocytes (Eckert et al., 2004). We have recently
identified the signal-transduction pathway that involves nPKC
isoforms d and Z, Ras, MEKK1, MEK3/6, p38d MAPK, and
targets AP-1 and CAAT/enhancer-binding protein transcrip-
tion factors to activate differentiation-dependent involucrin
gene expression in human keratinocytes (Efimova et al.,
1998, 2002, 2003; Efimova and Eckert, 2000; Eckert et al.,
2004). Our present results suggest that Pyk2 acts downstream
of PKC isoforms d and Z and upstream of MAPK pathway to
regulate hINV transcription. MAPKs, including extracellular
signal-regulated kinase 1/2, c-Jun N-terminal kinase 1/2, and
p38 MAPK, have been implicated as downstream targets of
Pyk2 in many cell systems (Avraham et al., 2000; Orr and
Murphy-Ullrich, 2004). Studies are in progress to determine
which specific MAPK isoform(s) play a functional role in
transmitting Pyk2-mediated signal in a pathway leading to
activation of involucrin expression and other differentiation
responses.
The data reported here provide evidence that the majority
of the endogenous Pyk2 protein is constitutively localized to
the cell nucleus in normal human epidermal keratinocytes
(Figures 1c–e, 2, 4 and 5). This is a remarkable and unique
pattern of subcellular distribution, as Pyk2 is generally
referred to as cytoplasmic or cytoskeleton-associated kinase
(Gelman, 2003). Pyk2 is localized to the cytoplasm and
perinuclear regions in fibroblasts, with a portion of Pyk2
located at the sites of cell–cell contacts (Matsuya et al., 1998).
In endothelial cells and in HaCaT cells, Pyk2 is distributed
throughout the cytosol (Keogh et al., 2002; Halfter et al.,
2005). In macrophages, which predominantly express Pyk2
rather than focal adhesion kinase, Pyk2 is localized to focal
complexes known as podosomes (Duong and Rodan, 2000).
In osteoclasts, Pyk2 is found is the sealing zone (Duong et al.,
1998). Pyk2 translocation to the nucleus in response to
gonadotropin releasing hormone has been reported in human
embryonic kidney 293 cells stably expressing the mouse
gonadotropin releasing hormone receptor (Farshori et al.,
2003). Recently, a nuclear localization of a 68 kDa proteo-
lytic fragment of Pyk2 has been described in chicken embryo
epiphyseal chondrocytes, whereas a full-length protein has
been found to accumulate predominantly in the cytoplasm
(Arcucci et al., 2006). The cytoplasmic Pyk2 immunostaining
has demonstrated a high degree of colocalization with the
mitochondria-specific probe, indicating a possibility of the
mitochondrial localization of Pyk2 in these cells (Arcucci
et al., 2006). Interestingly, a disruption of the C-terminal
proline-rich motif of Pyk2 by mutation of proline 859 to
alanine (P859A), results in a remarkable change in sub-
cellular distribution of the overexpressed mutant Pyk2 protein
in several fibroblast and epithelial cell lines: P859A mutant is
localized exclusively in the nucleus, whereas overexpressed
wild-type Pyk2 is cytoplasmic under normal cell culture
conditions (Aoto et al., 2002). Notably, overexpressed wild-
type Pyk2 also accumulates in the nucleus when the cells are
treated with an inhibitor of the nuclear export leptomycin B
(Aoto et al., 2002). These observations suggest that Pyk2 may
shuttle between the cytoplasm and the nucleus, and that a
defect in binding of the putative SH3 domain-containing
protein to the mutated proline-rich sequence of Pyk2 at
residue 859 influences nuclear-cytoplasmic traffic of this
kinase (Aoto et al., 2002). It is therefore reasonable to assume
that this putative SH3 domain-containing protein that may
anchor Pyk2 in the cytoplasm in other cell types, either fails
to interact with Pyk2 in keratinocytes, or is not expressed
in these cells. Alternatively, the nuclear export signal
sequence(s) mapped to the residues 29–400 of Pyk2 (Aoto
et al., 2002) may be masked from functioning in the nuclei
of keratinocytes, leading to inhibition of the nuclear export
of the kinase. Additional studies are warranted to elucidate
the exact mechanism of nuclear targeting of Pyk2 in
keratinocytes.
In summary, the present studies advance our under-
standing of signaling pathways activated in keratinocytes by
regulators of keratinocyte differentiation and provide new
insights into the functional significance of a non-receptor
tyrosine kinase Pyk2 signaling in epidermis. Future investiga-
tion will be needed to obtain a comprehensive picture of the
signaling pathways influenced by Pyk2 during keratinocyte
differentiation process as well as detailed information
regarding Pyk2-responsive target genes in skin.
MATERIALS AND METHODS
Approvals
The medical ethical committee of Washington University in St Louis
approved all described studies. The study was conducted according
to the Declaration of Helsinki Principles.
Reagents and antibodies
Keratinocyte serum-free medium, gentamicin, dispase, trypsin, and
Hank’s balanced salt solution were obtained from Invitrogen
(Carlsbad, CA). Phorbol ester (12-O-tetradecanoylphorbol-13-acet-
ate, TPA), dimethyl sulfoxide, Hoechst 33342, and polybrene
(hexadimethrine bromide) were purchased from Sigma (St Louis,
MO). BIS-IM, BAPTA-AM, PP2, and Rottlerin were obtained from
EMD Biosciences (San Diego, CA). Mouse monoclonal anti-Pyk2
antibody (clone 11, C-terminal) was obtained from BD Biosciences.
Rabbit polyclonal anti-Pyk2 antibodies were from BioLegend (San
Diego, CA) (N-terminal) and from Santa Cruz Biotechnology (H-102,
N-terminal). Phospho-specific rabbit polyclonal anti-Pyk2 phospho-
tyrosine-402 (pY402), pY580, and pY881 antibodies were purchased
from Biosource International (Camarillo, CA). Mouse monoclonal
anti-poly(ADP-ribose) polymerase antibody was from BD Bios-
ciences. Rabbit polyclonal anti-PKCd, anti-Src, anti-Fra1, and anti-
JunD antibodies were purchased from Santa Cruz Biotechnology.
Rabbit polyclonal anti-extracellular signal-regulated kinase 1/2,
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mouse monoclonal anti-b-actin, and mouse monoclonal anti-FLAG
M2 antibodies were obtained from Sigma. Rabbit polyclonal anti-
phospho-Src, anti-phospho-extracellular signal-regulated kinase 1/2,
and anti-phosho-p38 MAPK antibodies were from Cell Signaling
Technology (Danvers, MA). Mouse monoclonal anti-GFP antibody
was purchased from Covance Research Products (Berkeley, CA).
hINV-specific rabbit polyclonal antibody was generously provided
by Dr Richard Eckert (LaCelle et al., 1998). Horseradish peroxidase-
conjugated sheep anti-mouse IgG and donkey anti-rabbit IgG
antibodies were purchased from Amersham Biosciences (Piscat-
away, NJ). CyTM 3-conjugated goat anti-mouse IgG and goat anti-
rabbit IgG were obtained from Jackson ImmunoResearch Labora-
tories (West Grove, PA). AlexaFluor 488 goat anti-mouse IgG and
goat anti-rabbit IgG were from Invitrogen. PC12 cell lysate was
purchased from Santa Cruz Biotechnology.
Plasmids
hINV promoter construct pINV-2473 was kindly provided by Dr
Richard Eckert (Welter et al., 1995; Efimova et al., 1998). This
construct includes nucleotides 2473/7 of the hINV promoter,
linked to the luciferase reporter gene in pGL2-Basic (Welter et al.,
1995). All positions are defined relative to the hINV gene
transcription start site. Expression vector encoding wild-type FLAG
epitope-tagged Pyk2, cloned in pcDNA3, was generously provided
by Dr Shalom Avraham (Park et al., 2004).
Recombinant adenoviruses
Replication-deficient adenoviruses encoding wild-type PKCd and
PKCZ were kindly provided by Dr Toshio Kuroki (Ohba et al., 1998).
Adenovirus encoding wild-type Pyk2 was a generous gift from Dr
Allen Samarel (Heidkamp et al., 2005). An empty control adenovirus
was previously described (Dashti et al., 2001). Recombinant
adenoviruses were propagated in 293 cells and purified by cesium
chloride centrifugation. Amplification of Pyk2 adenovirus was
provided by ViraQuest (North Liberty, IA). The optimal multiplicity
of infection was determined using the GFP-encoding adenovirus.
Keratinocytes were infected with each adenovirus at the indicated
multiplicity of infection in the presence of 2.5 mg/ml polybrene.
Cell culture, transient transfection, and luciferase assay
Normal human epidermal keratinocytes were isolated from neonatal
foreskins as decribed previously (Welter et al., 1995). Keratinocytes
were cultured in keratinocyte serum-free medium at 371C under 5%
CO2. Third passage keratinocytes were used in this study. For
transient transfection, keratinocytes were grown in 35-mm culture
dishes until approximately 50% confluent. The cells were then co-
transfected with 1 mg involucrin promoter reporter plasmid and 1mg
of either empty control expression vector, or Pyk2 expression
plasmid, using FuGENE 6 Transfection Reagent (Roche Applied
Science, Indianapolis, IN) according to manufacturer’s instructions.
After 48 hours keratinocytes were treated with keratinocyte serum-
free medium in the presence or absence of TPA. After an additional
24 hours, the cells were washed with phosphate-buffered saline, and
cell lysates were prepared using cell culture lysis reagent (Promega,
Madison, WI). Luciferase activity was measured using Luciferase
Assay System (Promega) and Berthold luminometer Lumat LB 9507.
All assays were performed in triplicate, and each experiment was
repeated a minimum of three times.
Cell extract preparation and immunoblot analysis
Total cell extracts were prepared from cultured human epidermal
keratinocytes as previously described (Efimova et al., 1998; Agarwal
et al., 1999). Briefly, the cells were harvested by scraping in the lysis
buffer containing 20 mM Tris (pH 7.5), 150 mM NaCl, 1 mM EDTA,
1 mM EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM
b-glycerophosphate, 1 mM Na3VO4, 1mg/ml leupeptin, and 1 mM
phenylmethylsulphonyl fluoride. Nuclear extracts were isolated
according to the method described by Schreiber et al. (1989). The
protein content of the samples was determined using Bradford
Protein Assay reagent (Bio-Rad, Hercules, CA). Equal quantities of
extracted protein were separated by electrophoresis on 8 or 10%
SDS-PAGE and transferred to nitrocellulose membranes. Nonspecific
binding sites were blocked, and the membranes were incubated with
an indicated primary antibody followed by an appropriate horse-
radish peroxidase-conjugated secondary antibody. Secondary anti-
body binding was detected using enhanced chemiluminescence
detection system (Amersham Biosciences).
RT-PCR analysis of Pyk2 mRNA levels
Total RNA was extracted from cultured keratinocytes using RNeasy
RNA isolation kit (Qiagen, Valencia, CA) according to manufac-
turer’s instructions. RT-PCR was performed using Titan One Tube
RT-PCR System (Roche Applied Science) as described (Efimova
et al., 2003). Briefly, PCR reactions (25 ml) contained 1 mg RNA,
20 mM of each primer, 1.5 mM MgCl2, 1ml of enzyme mixture, which
included avian myeloblastosis virus reverse transcriptase, Taq DNA
polymerase, proofreading polymerase, and optimized reaction
buffer. The latter contained 0.2 mM deoxynucleoside triphosphates
and 5 mM dithiothreitol. The reverse transcription step was carried
out at 501C for 30 minutes. The complex was denatured at 941C for
one cycle, and amplified for 35 cycles (denaturation at 941C for
10 seconds, annealing at 551C for 30 seconds, and elongation at
681C for 2 minutes, plus time increment of 5 seconds per cycle
repeated during the last 25 cycles, followed by an additional
elongation step at 681C for 7 minutes). PCR products were separated
on a 1.5% agarose gel. The nucleotide sequence for the Pyk2-
specific upstream primer was 50-CGGGCCGTGCTGGAGCTCAA-30
(positions 2958–2977), the sequence for the downstream primer was
50-GTCCGTGAAGATGACGGCAA-30 (positions 3084–3103) (Avra-
ham et al., 1995). The expected size of the PCR product is 144 bp.
b-Actin RNA levels were monitored as an internal control. The Titan
One Tube RT-PCR kit (Roche Applied Science) supplied specific
primers for b-actin.
Immunofluorescence staining and confocal microscopy
Human keratinocytes grown on glass coverslips were fixed with 4%
paraformaldehyde for 30 minutes at room temperature, and blocked
in phosphate-buffered saline containing 1% BSA, and 0.15% Triton-
X 100 for 30 minutes at room temperature. The coverslips were
incubated with primary antibody overnight at 41C in a humid
chamber, followed by incubation with the appropriate fluoro-
chrome-conjugated secondary antibody for 2 hours at room tem-
perature. Nuclei were stained with Hoechst 33342 dye (Sigma). The
coverslips were mounted in a solution containing 50% glycerol and
2% n-propyl gallate (Sigma) in phosphate-buffered saline, and
examined by laser scanning confocal microscopy. Formalin-fixed,
paraffin-embedded sections of neonatal human foreskins or healthy
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adult human skin specimens, derived from patients undergoing
breast and abdominal reduction surgery, were deparaffinized,
rehydrated, and subjected to microwave antigen retrieval procedure
in 10 mM citrate buffer (pH 6.0). Sections were blocked, incubated
with primary and secondary antibodies as described above, and
analyzed by laser scanning confocal microscopy. The use of human
tissue samples for this study was approved by Washington University
Medical Center Human Studies Committee.
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